
Michael A. Matey
Examiner (ID: 10696, Phone: (571)270-5648 , Office: P/2835 )
| Most Active Art Unit | 2835 |
| Art Unit(s) | 2841, 2835 |
| Total Applications | 842 |
| Issued Applications | 659 |
| Pending Applications | 76 |
| Abandoned Applications | 122 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17732542
[patent_doc_number] => 20220218001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/441731
[patent_app_country] => US
[patent_app_date] => 2020-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 177630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441731 | REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS | Apr 4, 2020 | Pending |
Array
(
[id] => 17670155
[patent_doc_number] => 20220183322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/441714
[patent_app_country] => US
[patent_app_date] => 2020-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441714 | REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS | Apr 4, 2020 | Abandoned |
Array
(
[id] => 17548516
[patent_doc_number] => 20220119857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => Use of Muramic Acid as a Biomarker for Gastrointestinal Peptidoglycan Hydrolysis
[patent_app_type] => utility
[patent_app_number] => 17/434740
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434740
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434740 | Use of Muramic Acid as a Biomarker for Gastrointestinal Peptidoglycan Hydrolysis | Mar 19, 2020 | Pending |
Array
(
[id] => 18269220
[patent_doc_number] => 20230090462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/439251
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439251 | ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF | Mar 15, 2020 | Pending |
Array
(
[id] => 17689366
[patent_doc_number] => 20220196659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR DETERMINING EFFICACY
[patent_app_type] => utility
[patent_app_number] => 17/435911
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435911 | METHOD FOR DETERMINING EFFICACY | Mar 5, 2020 | Pending |
Array
(
[id] => 16267403
[patent_doc_number] => 20200268890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => Dosing Regimens For The Treatment Of Fabry Disease
[patent_app_type] => utility
[patent_app_number] => 16/806404
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806404 | Dosing Regimens For The Treatment Of Fabry Disease | Mar 1, 2020 | Abandoned |
Array
(
[id] => 17595708
[patent_doc_number] => 20220145282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Cell-Free Compositions for ATP Regeneration and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/430634
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430634 | Cell-Free Compositions for ATP Regeneration and Uses Thereof | Feb 11, 2020 | Abandoned |
Array
(
[id] => 17548419
[patent_doc_number] => 20220119760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => ISOLATED CELL CULTURE COMPONENTS AND METHODS FOR ISOLATING THE SAME FROM LIQUID CELL CULTURE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/428063
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428063 | ISOLATED CELL CULTURE COMPONENTS AND METHODS FOR ISOLATING THE SAME FROM LIQUID CELL CULTURE MEDIUM | Feb 4, 2020 | Pending |
Array
(
[id] => 17458806
[patent_doc_number] => 20220072110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS
[patent_app_type] => utility
[patent_app_number] => 17/422962
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422962 | PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS | Jan 23, 2020 | Pending |
Array
(
[id] => 15926137
[patent_doc_number] => 20200154702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => Stable Bioactive Substances and Methods of Making
[patent_app_type] => utility
[patent_app_number] => 16/751708
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751708
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751708 | Stable Bioactive Substances and Methods of Making | Jan 23, 2020 | Abandoned |
Array
(
[id] => 17441886
[patent_doc_number] => 20220062391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => ENHANCING EPITHELIAL OR ENDOTHELIAL BARRIER FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/420732
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420732
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420732 | ENHANCING EPITHELIAL OR ENDOTHELIAL BARRIER FUNCTION | Jan 14, 2020 | Abandoned |
Array
(
[id] => 16087499
[patent_doc_number] => 20200197736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => BIOLOGICAL COMPOSITION FOR DEGRADING PLANT PESTICIDE RESIDUES AND THE APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/710545
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710545
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710545 | BIOLOGICAL COMPOSITION FOR DEGRADING PLANT PESTICIDE RESIDUES AND THE APPLICATION THEREOF | Dec 10, 2019 | Abandoned |
Array
(
[id] => 17095516
[patent_doc_number] => 20210283307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHOD FOR EXTRACTING EXTRACELLULAR MATRIX USING SUPERCRITICAL FLUID, AND EXTRACELLULAR MATRIX BIOMATERIAL FOR TISSUE REGENERATION PRODUCED THEREBY
[patent_app_type] => utility
[patent_app_number] => 17/257541
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257541
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257541 | METHOD FOR EXTRACTING EXTRACELLULAR MATRIX USING SUPERCRITICAL FLUID, AND EXTRACELLULAR MATRIX BIOMATERIAL FOR TISSUE REGENERATION PRODUCED THEREBY | Nov 21, 2019 | Pending |
Array
(
[id] => 15931739
[patent_doc_number] => 20200157503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS
[patent_app_type] => utility
[patent_app_number] => 16/690888
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16690888
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/690888 | HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS | Nov 20, 2019 | Abandoned |
Array
(
[id] => 15646411
[patent_doc_number] => 20200085735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => Novel methods for delivering therapeutics agents to the eye via the nasal passages
[patent_app_type] => utility
[patent_app_number] => 16/690197
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16690197
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/690197 | Novel methods for delivering therapeutics agents to the eye via the nasal passages | Nov 20, 2019 | Pending |
Array
(
[id] => 17291029
[patent_doc_number] => 20210386868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => EXTRACELLULAR VESICLES FOR REPLACEMENT OF UREA CYCLE PROTEINS & NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/281535
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281535
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/281535 | EXTRACELLULAR VESICLES FOR REPLACEMENT OF UREA CYCLE PROTEINS & NUCLEIC ACIDS | Nov 17, 2019 | Abandoned |
Array
(
[id] => 15616009
[patent_doc_number] => 20200078409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/684142
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/684142 | METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME | Nov 13, 2019 | Abandoned |
Array
(
[id] => 17343935
[patent_doc_number] => 20220010266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => Microbial hosts engineered for increased tolerance to temperature shifts
[patent_app_type] => utility
[patent_app_number] => 17/291620
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291620 | Microbial hosts engineered for increased tolerance to temperature shifts | Nov 7, 2019 | Pending |
Array
(
[id] => 17292219
[patent_doc_number] => 20210388058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => METHOD FOR MANUFACTURING HIGHLY PURIFIED LACTOFERRIN AND LACTOPEROXIDASE FROM MILK, COLOSTRUM AND ACID OR SWEET WHEY
[patent_app_type] => utility
[patent_app_number] => 17/291081
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291081
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291081 | METHOD FOR MANUFACTURING HIGHLY PURIFIED LACTOFERRIN AND LACTOPEROXIDASE FROM MILK, COLOSTRUM AND ACID OR SWEET WHEY | Nov 5, 2019 | Abandoned |
Array
(
[id] => 15832387
[patent_doc_number] => 20200131475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS
[patent_app_type] => utility
[patent_app_number] => 16/669931
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16669931
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/669931 | METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS | Oct 30, 2019 | Pending |